InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Pepose Jay, Director. Insider active across 1 company, notably Ocuphire Pharma, Inc.. Cumulatively, 4 filings have been published. Breakdown: 4 buys · 0 sell. Total volume traded: €155k. Activity tracked since 13 September 2021. The latest transaction was disclosed on 13 December 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
8,250 shares@ US$3.6517.2% of flowCommon StockSEC:0001140361-21-041622:0
Ideal exit: 9 Sept 2022 (T+270)
8,250 shares@ US$3.6534.4% of flowCommon StockSEC:0001140361-21-041622
Ideal exit: 9 Sept 2022 (T+270)
12,631 shares@ US$4.7532.8% of flowCommon StockSEC:0001140361-21-031308:0
Ideal exit: 10 Jun 2022 (T+270)
12,631 shares@ US$4.7565.6% of flowCommon StockSEC:0001140361-21-031308
Ideal exit: 10 Jun 2022 (T+270)
4 of 4 declarations
About Pepose Jay
Jay Pepose serves as a Board Member at Ocuphire Pharma, Inc. In this role, he participates in the governance of the company, providing his expertise to assist in strategic decision-making. His experience in the pharmaceutical sector allows him to contribute to the company's direction and performance improvement.
